Boothbay Fund Management, LLC Horizon Therapeutics Public LTD CO Call Options Transaction History

Boothbay Fund Management, LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Nov 14, 2022	SELL	$58.92 - $84.67 $3.71 Million - $5.33 Million	-62,900 Reduced 84.43%	11,600 $718,000
Q2 2022 Aug 15, 2022	BUY	$79.4 - $116.36 $4.5 Million - $6.6 Million	56,700 Added 318.54%	74,500 $5.94 Million
Q1 2022 May 16, 2022	SELL	$86.42 - $109.81 $7.86 Million - $9.99 Million	-91,000 Reduced 83.64%	17,800 $1.87 Million
Q4 2021 Feb 14, 2022	BUY	$98.56 - $119.91 $6.56 Million - $7.99 Million	66,600 Added 157.82%	108,800 $11.7 Million
Q3 2021 Nov 15, 2021	BUY	$91.91 - $110.37 $1.29 Million - $1.55 Million	14,000 Added 49.65%	42,200 $4.62 Million

Q2 2021 Aug 16, 2021	BUY	$86.24 - $95.92 $2.43 Million - $2.7 Million	28,200 New	28,200 $2.64 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.